HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
COG6
component of oligomeric golgi complex 6
Chromosome 13 Β· 13q14.11
NCBI Gene: 57511Ensembl: ENSG00000133103.19HGNC: HGNC:18621UniProt: A0A140VJG7
59PubMed Papers
22Diseases
0Drugs
34Pathogenic Variants
FUNCTIONAL ROLE
Transporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
retrograde transport, vesicle recycling within GolgiCOG complexGolgi organizationprotein bindingCOG6-congenital disorder of glycosylationhypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndromeneurodegenerative diseasegenetic disorder
✦AI Summary

COG6 (component of oligomeric Golgi complex 6) is a subunit of the conserved oligomeric Golgi (COG) complex essential for maintaining Golgi homeostasis and protein glycosylation. The COG complex regulates intra-Golgi vesicle-mediated transport and retrograde recycling, which are critical for proper presentation of surface glycoproteins including sialic acid receptors 1. COG6 deficiency impairs both N- and O-linked protein glycosylation, resulting in destabilization of Golgi glycosylation machinery 2. Biallelic COG6 variants cause COG6-CDG (congenital disorder of glycosylation type 2L), a severe multisystem disorder characterized by neurological involvement, developmental delay, facial dysmorphism, arthrogryposis, hepatic dysfunction, gastrointestinal abnormalities, and central nervous system malformations including corpus callosum dysgenesis and cerebellar hypoplasia 342. COG6 variants have also been identified in lethal fetal akinesia phenotypes 5. Beyond genetic disease, COG6 variants show epigenetic dysregulation in pulmonary arterial hypertension 6, and a regulatory variant near COG6 is a shared genetic risk locus for rheumatoid arthritis and systemic lupus erythematosus 7. Additionally, COG6 functions as an essential host factor for influenza A virus replication through maintaining proper receptor glycosylation and regulating viral protein degradation 1.

Sources cited
1
COG6 is required for proper Golgi homeostasis, surface sialic acid receptor presentation, and viral protein stabilization in IAV infection
PMID: 40910953
2
COG6 deficiency causes both N- and O-protein glycosylation defects and destabilization of Golgi glycosylation machinery
PMID: 35068072
3
Biallelic COG6 variants cause congenital disorder of glycosylation with cholestasis, diarrhea, facial dysmorphism, and brain atrophy
PMID: 39528286
4
COG6 mutations cause CDG2L with prenatal phenotype including arthrogryposis, heart malformation, and central nervous system abnormalities
PMID: 40213872
5
COG6 variants identified in fetuses with lethal multiple congenital contractures and fetal akinesia
PMID: 38278647
6
COG6 locus shows hypermethylation associated with pulmonary arterial hypertension
PMID: 38184627
7
COG6 genetic variant is a shared risk locus for rheumatoid arthritis and systemic lupus erythematosus through type I interferon signaling pathway
PMID: 27193031
8
COG6-CDG phenotype includes growth retardation, developmental delay, microcephaly, liver and gastrointestinal disease, and disorders of sex development
PMID: 32683677
Disease Associationsβ“˜22
COG6-congenital disorder of glycosylationOpen Targets
0.79Strong
hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndromeOpen Targets
0.75Strong
neurodegenerative diseaseOpen Targets
0.55Moderate
genetic disorderOpen Targets
0.45Moderate
Uterine leiomyomaOpen Targets
0.45Moderate
uterine fibroidOpen Targets
0.41Moderate
rheumatoid arthritisOpen Targets
0.41Moderate
asthmaOpen Targets
0.39Weak
autoimmune diseaseOpen Targets
0.38Weak
thyroiditisOpen Targets
0.35Weak
vein disorderOpen Targets
0.35Weak
Crohn's diseaseOpen Targets
0.35Weak
ACPA-positive rheumatoid arthritisOpen Targets
0.34Weak
Intellectual disabilityOpen Targets
0.33Weak
musculoskeletal system diseaseOpen Targets
0.31Weak
lower respiratory tract diseaseOpen Targets
0.31Weak
atrophic gastritisOpen Targets
0.30Weak
Abnormal erythrocyte morphologyOpen Targets
0.30Weak
obesityOpen Targets
0.29Weak
Varicose veinsOpen Targets
0.28Weak
Congenital disorder of glycosylation 2LUniProt
Shaheen syndromeUniProt
Pathogenic Variants34
NM_020751.3(COG6):c.298-1G>ALikely pathogenic
COG6-congenital disorder of glycosylation;Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome|not provided
β˜…β˜…β˜†β˜†2025
NM_020751.3(COG6):c.1167-24A>GPathogenic
Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome|Hypohidrosis;Intellectual disability|not provided|COG6-related disorder|COG6-congenital disorder of glycosylation
β˜…β˜…β˜†β˜†2025
NM_020751.3(COG6):c.1535T>G (p.Leu512Ter)Pathogenic
not provided|COG6-congenital disorder of glycosylation;Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome|COG6-congenital disorder of glycosylation
β˜…β˜…β˜†β˜†2025β†’ Residue 512
NM_020751.3(COG6):c.511C>T (p.Arg171Ter)Pathogenic
COG6-congenital disorder of glycosylation|COG6-congenital disorder of glycosylation;Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 171
NM_020751.3(COG6):c.651_654del (p.Leu217fs)Pathogenic
Inborn genetic diseases|COG6-congenital disorder of glycosylation;Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome
β˜…β˜…β˜†β˜†2023β†’ Residue 217
NM_020751.3(COG6):c.1166+1G>ALikely pathogenic
Inborn genetic diseases|COG6-related disorder
β˜…β˜…β˜†β˜†2023
NM_020751.3(COG6):c.548dup (p.Lys184fs)Pathogenic
not provided|COG6-congenital disorder of glycosylation
β˜…β˜…β˜†β˜†2022β†’ Residue 184
NM_020751.3(COG6):c.1078C>T (p.Arg360Ter)Pathogenic
COG6-congenital disorder of glycosylation;Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 360
NM_020751.3(COG6):c.695-8T>GLikely pathogenic
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome
β˜…β˜†β˜†β˜†2025
NM_020751.3(COG6):c.984_994del (p.Leu329fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 329
NM_020751.3(COG6):c.686G>A (p.Trp229Ter)Pathogenic
Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome;COG6-congenital disorder of glycosylation
β˜…β˜†β˜†β˜†2025β†’ Residue 229
NM_020751.3(COG6):c.785A>G (p.Tyr262Cys)Likely pathogenic
COG6-congenital disorder of glycosylation|not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 262
NM_020751.3(COG6):c.1826+2T>CLikely pathogenic
COG6-congenital disorder of glycosylation
β˜…β˜†β˜†β˜†2024
NM_020751.3(COG6):c.691C>T (p.Gln231Ter)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 231
NM_020751.3(COG6):c.1646G>T (p.Gly549Val)Pathogenic
COG6-congenital disorder of glycosylation|not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 549
NM_020751.3(COG6):c.1060del (p.Cys354fs)Likely pathogenic
COG6-related disorder
β˜…β˜†β˜†β˜†2023β†’ Residue 354
NM_020751.3(COG6):c.153+392A>GPathogenic
COG6-congenital disorder of glycosylation
β˜…β˜†β˜†β˜†2023
NM_020751.3(COG6):c.1672C>T (p.Gln558Ter)Pathogenic
COG6-congenital disorder of glycosylation
β˜…β˜†β˜†β˜†2023β†’ Residue 558
NM_020751.3(COG6):c.1585-2A>GLikely pathogenic
COG6-congenital disorder of glycosylation;Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome
β˜…β˜†β˜†β˜†2023
NM_020751.3(COG6):c.789-1G>TLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2022
View on ClinVar β†—
Related Genes
EXOC7Protein interaction100%YKT6Protein interaction99%VTI1AProtein interaction94%COG5Protein interaction92%COG8Protein interaction91%VPS51Protein interaction91%
Tissue Expression6 tissues
Heart
100%
Brain
47%
Ovary
44%
Liver
34%
Bone Marrow
24%
Lung
23%
Gene Interaction Network
Click a node to explore
COG6EXOC7YKT6VTI1ACOG5COG8VPS51
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q9Y2V7
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.06LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.76 [0.56–1.06]
RankingsWhere COG6 stands among ~20K protein-coding genes
  • #7,753of 20,598
    Most Researched59
  • #1,703of 5,498
    Most Pathogenic Variants34
  • #10,610of 17,882
    Most Constrained (LOEUF)1.06
Genes detectedCOG6
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 20301507
1.00
2
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension.
PMID: 38184627
Nat Commun Β· 2024
0.90
3
A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus.
PMID: 27193031
Ann Rheum Dis Β· 2017
0.80
4
[Clinical features and genetic analysis of a child with Congenital disorder of glycosylation due to novel variants of COG6 gene].
PMID: 39528286
Zhonghua Yi Xue Yi Chuan Xue Za Zhi Β· 2024
0.70
5
Clinical and molecular characteristics of 26 fetuses with lethal multiple congenital contractures.
PMID: 38278647
Clin Genet Β· 2024
0.60